Research Article
MicroRNA-24 Modulates Aflatoxin B1-Related Hepatocellular Carcinoma Prognosis and Tumorigenesis
Table 3
Expression levels of miR-24 and clinicopathological features of cases.
| | Low expression | High expression | OR (95% CI)a | P | | n | % | n | % |
| AFB1 exposure | | | | | | 3.10 × 10−2 | Low level | 59 | 64.8 | 56 | 48.3 | Reference | | High level | 32 | 35.2 | 60 | 51.7 | 1.92 (1.06–3.46) | | Tumor size | | | | | | 1.91 × 10−2 | ≤5 cm | 53 | 58.2 | 48 | 41.4 | Reference | | >5 cm | 38 | 41.8 | 68 | 58.6 | 2.01 (1.12–3.60) | | Tumor grade | | | | | | 3.92 × 10−2 | I-II | 72 | 79.1 | 78 | 67.3 | Reference | | III-IV | 19 | 20.9 | 38 | 32.7 | 2.10 (1.04–4.27) | | MVD | | | | | | 1.93 × 10−2 | Low | 50 | 54.9 | 38 | 32.8 | Reference | | High | 41 | 45.1 | 78 | 67.2 | 2.62 (1.43–4.81) | |
|
|
Adjusted by age, sex, race, HBV and HCV infection status, and smoking and drinking status.
|